Brief: Hofseth Biocare Q3 Revenue NOK 67.9 Million
08/11/2024 07:15
Nov 08 (Reuters) - Hofseth Biocare Q3 EBIT NOK -30.5 million
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering